Product Information
ZOVIA 1-35 TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.3790 per EA under NDC 75907008762. Its NADAC has been published 103 times since Oct 16, 2024.
FDA first approved this application on Feb 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907008762
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA209548FDA Approved
2/11/2019
TE Code
AB
On Market Since
6/1/2024
Price Statistics
The NADAC for ZOVIA 1-35 TABLET has been published 103 times since Oct 16, 2024, and over the history we have for it it has declined 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3790 per EA |
|---|---|
| All-time high | $0.4030 (Nov 13, 2024) |
| All-time low | $0.2253 (Nov 20, 2024) |
| 52-week high | $0.3819 |
| 52-week low | $0.3004 |
| Median price | $0.3449 |
| Average price | $0.3433 |
| Largest weekly change | -44.1% (Nov 20, 2024) |
| Weeks tracked | 103 |
| Tracking since | Oct 16, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ethynodiol Diacetate and Ethinyl Estradiol Tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOVIA 1-35 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOVIA 1-35 TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.3790 per EA (NDC 75907008762), effective Sep 30, 2026.
How has the price of ZOVIA 1-35 TABLET changed over time?
Over the history we have for it, the NADAC for ZOVIA 1-35 TABLET has declined 5.6%. It has been tracked across 103 weekly CMS publications since Oct 16, 2024.
What are the highest and lowest recorded NADAC prices for ZOVIA 1-35 TABLET?
Since Oct 16, 2024, the NADAC for ZOVIA 1-35 TABLET has ranged from a low of $0.2253 (Nov 20, 2024) to a high of $0.4030 (Nov 13, 2024), with a median of $0.3449 per EA.
Are there cheaper alternatives to ZOVIA 1-35 TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOVIA 1-35 TABLET, is $0.3449 per EA — about 9% below ZOVIA 1-35 TABLET.
Who manufactures ZOVIA 1-35 TABLET?
ZOVIA 1-35 TABLET (NDC 75907008762) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.